Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Cost of Revenue: 2019-2024

Historic Cost of Revenue for Eton Pharmaceuticals (ETON) over the last 6 years, with Dec 2024 value amounting to $15.6 million.

  • Eton Pharmaceuticals' Cost of Revenue rose 263.10% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year increase of 94.54%. This contributed to the annual value of $15.6 million for FY2024, which is 47.43% up from last year.
  • As of FY2024, Eton Pharmaceuticals' Cost of Revenue stood at $15.6 million, which was up 47.43% from $10.6 million recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Cost of Revenue registered a high of $15.6 million during FY2024, and its lowest value of $286,000 during FY2020.
  • Moreover, its 3-year median value for Cost of Revenue was $10.6 million (2023), whereas its average is $11.0 million.
  • In the last 5 years, Eton Pharmaceuticals' Cost of Revenue plummeted by 36.87% in 2020 and then spiked by 888.46% in 2021.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Cost of Revenue stood at $286,000 in 2020, then skyrocketed by 888.46% to $2.8 million in 2021, then soared by 145.24% to $6.9 million in 2022, then soared by 52.62% to $10.6 million in 2023, then spiked by 47.43% to $15.6 million in 2024.